Self-administered screening for mild cognitive impairment: initial validation of a computerized test battery

Area of Science:

• Neuropsychology
• Gerontology
• Cognitive Science

Background:

• Mild cognitive impairment (MCI) affects a significant portion of the aging population.
• Early detection of MCI is crucial for timely intervention and management.
• Existing screening tools may have limitations in accessibility or diagnostic accuracy.

Purpose of the Study:

• To evaluate the Computer-Administered Neuropsychological Screen for Mild Cognitive Impairment (CANS-MCI) as a screening tool.
• To assess the reliability and validity of the CANS-MCI in detecting mild cognitive impairment.
• To determine if CANS-MCI can identify elders warranting more intensive cognitive testing.

Main Methods:

• A cohort of 310 community-dwelling elders participated in the study.
• The CANS-MCI, a touch screen battery, was administered to assess cognitive function.
• Test-retest reliability and concurrent validity were examined using established statistical methods.
• Confirmatory factor analysis was employed to validate the underlying cognitive dimensions measured.

Main Results:

• The CANS-MCI demonstrated significant one-month test-retest reliability (p<0.05-p<0.001).
• Concurrent validity was high, with significant correlations (p<0.001) against the Weschler Memory Scale-Revised (WMS-R) LMS-II.
• Confirmatory factor analysis supported a three-factor model (memory, language/spatial fluency, executive function/mental control) with strong goodness-of-fit indicators.

Conclusions:

• The CANS-MCI exhibits strong reliability and diagnostic validity for detecting mild cognitive impairment.
• The tool effectively measures key cognitive dimensions relevant to MCI.
• CANS-MCI shows significant promise as a valid and reliable screening instrument for early cognitive impairment.